Effects of an Integrative Day-care Clinic Program for Breast Cancer Patients During Chemotherapy
NCT ID: NCT03868865
Last Updated: 2019-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
57 participants
INTERVENTIONAL
2012-08-07
2015-04-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mind-Body Medicine Day Care Clinic in Breast Cancer Patients Undergoing Endocrine Therapy
NCT02669576
TCM Therapy Program Impact on Breast Cancer Patients' Vital Energy
NCT06337214
Adjuvant Acupuncture Care for Breast Cancer Patients Experiencing Side Effects From Chemotherapy
NCT00885183
Effects of a Physical Exercise and Health Education Program for Women With Breast Cancer Undergoing Chemotherapy
NCT04554823
Barriers to Therapeutic Exercise in Breast Cancer Patients Before, During, and After Chemotherapy
NCT06828614
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Integrative mind-body-medicine group program
The 66 hour program encompasses mindfulness training, yoga, moderate exercise, nutrition, naturopathic self-help strategies, cognitive restructuring and acupuncture for the management of side effects caused by chemotherapy.
Integrative mind-body-medicine group program
The mind-body-medicine group program focuses on support in coping with the disease, in lifestyle modification and in reduction of chemotherapy induced side effects. The self-contained modules of the mind-body-medicine group program can be followed in an individual order, to allow adoption to different chemotherapy concepts and continued access is possible. Patients can join in the group program eleven times for six hours each visit. They participate in every one of the eleven modules once.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Integrative mind-body-medicine group program
The mind-body-medicine group program focuses on support in coping with the disease, in lifestyle modification and in reduction of chemotherapy induced side effects. The self-contained modules of the mind-body-medicine group program can be followed in an individual order, to allow adoption to different chemotherapy concepts and continued access is possible. Patients can join in the group program eleven times for six hours each visit. They participate in every one of the eleven modules once.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* receiving chemotherapy
* at least 18 years old
* written informed consent
* willing and physically/mentally able to participate in a six hours day care clinic program eleven times during chemotherapy.
Exclusion Criteria
* physical or mental disabilities resulting in ineligibility for participation in the program or filling out the questionnaires.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universität Duisburg-Essen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. med. Petra Voiss
Study physician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kliniken Essen-Mitte
Essen, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-7909-BO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.